172 related articles for article (PubMed ID: 15163236)
41. Primary orbital plasmacytoma: A case report.
Sen S; Kashyap S; Betharia S
Orbit; 2003 Dec; 22(4):317-9. PubMed ID: 14685909
[TBL] [Abstract][Full Text] [Related]
42. Biphenotypic plasma cell myeloma: two cases of plasma cell neoplasm with a coexpression of kappa and lambda light chains.
Jiwani S; Bornhost J; Alapat D
Int J Clin Exp Pathol; 2015; 8(7):8536-44. PubMed ID: 26339430
[TBL] [Abstract][Full Text] [Related]
43. Immunoperoxidase staining of bone marrow sections.
Hitzman JL; Li CY; Kyle RA
Cancer; 1981 Dec; 48(11):2438-46. PubMed ID: 6794902
[TBL] [Abstract][Full Text] [Related]
44. Leukemia-associated changes identified by quantitative flow cytometry. III. B-cell gating in CD37/kappa/lambda clonality test.
Peters RE; Janossy G; Ivory K; al-Ismail S; Mercolino T
Leukemia; 1994 Nov; 8(11):1864-70. PubMed ID: 7967732
[TBL] [Abstract][Full Text] [Related]
45. Isolated laryngeal plasmacytosis.
El Naderi S; Primov-Fever A; Brasnu D; Badoual C
Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Nov; 130(5):293-5. PubMed ID: 23835073
[TBL] [Abstract][Full Text] [Related]
46. Testicular plasmacytoma. A case report with immunohistochemical studies and literature review.
Oppenheim PI; Cohen S; Anders KH
Arch Pathol Lab Med; 1991 Jun; 115(6):629-32. PubMed ID: 1903919
[TBL] [Abstract][Full Text] [Related]
47. Extramedullary plasmacytomas presenting as mediastinal masses: clinicopathologic study of two cases preceding the onset of multiple myeloma.
Moran CA; Suster S; Fishback NF; Koss MN
Mod Pathol; 1995 Apr; 8(3):257-9. PubMed ID: 7617650
[TBL] [Abstract][Full Text] [Related]
48. Diagnostic significance of kappa/lambda and lambda/kappa ratio in paraproteinemias.
Tichý M; Hrncír Z
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1982; 25(3-4):313-8. PubMed ID: 6820852
[No Abstract] [Full Text] [Related]
49. Cutaneous light chain amyloidosis with multiple myeloma: A concise review.
Andrei M; Wang JC
Hematol Oncol Stem Cell Ther; 2019 Jun; 12(2):71-81. PubMed ID: 30261180
[TBL] [Abstract][Full Text] [Related]
50. Automated kappa and lambda light chain mRNA expression for the assessment of B-cell clonality in cutaneous B-cell infiltrates: its utility and diagnostic application.
Magro C; Crowson AN; Porcu P; Nuovo GJ
J Cutan Pathol; 2003 Sep; 30(8):504-11. PubMed ID: 12950502
[TBL] [Abstract][Full Text] [Related]
51. Light chain isotype associated suppression of surface immunoglobulin expression on peripheral blood lymphocytes in myeloma during plateau phase.
Wearne A; Joshua DE; Kronenberg H
Br J Haematol; 1984 Nov; 58(3):483-9. PubMed ID: 6437432
[TBL] [Abstract][Full Text] [Related]
52. Clinico-pathological aspects of canine cutaneous and mucocutaneous plasmacytomas.
Cangul IT; Wijnen M; Van Garderen E; van den Ingh TS
J Vet Med A Physiol Pathol Clin Med; 2002 Aug; 49(6):307-12. PubMed ID: 12227474
[TBL] [Abstract][Full Text] [Related]
53. Amyloidomas of the nervous system: a monoclonal B-cell disorder with monotypic amyloid light chain lambda amyloid production.
Laeng RH; Altermatt HJ; Scheithauer BW; Zimmermann DR
Cancer; 1998 Jan; 82(2):362-74. PubMed ID: 9445195
[TBL] [Abstract][Full Text] [Related]
54. Multiple primary cutaneous plasmacytomas.
Green T; Grant J; Pye R; Marcus R
Arch Dermatol; 1992 Jul; 128(7):962-5. PubMed ID: 1626965
[TBL] [Abstract][Full Text] [Related]
55. Huge cutaneous plasmacytomas complicating multiple myeloma.
Shpilberg O; Yaniv R; Levy Y; Trau H; Ben-Bassat I
Clin Exp Dermatol; 1994 Jul; 19(4):324-6. PubMed ID: 7955475
[TBL] [Abstract][Full Text] [Related]
56. The usefulness of the immunoglobulin P.A.P. method for the prognostic evaluation of head and neck plasmacytoma.
Luboinski B; Caillaud JM; Leridant AM; Bosq J; Micheau C
Pathol Res Pract; 1985 May; 179(6):629-30. PubMed ID: 3927274
[No Abstract] [Full Text] [Related]
57. [The proportion of kappa and lambda light chains among monotypic IgG and IgA].
Nikolić V; Dovezenski N; Milosević-Jovcić N
Srp Arh Celok Lek; 1986; 114(11-12):991-9. PubMed ID: 3109038
[No Abstract] [Full Text] [Related]
58. Prevalence and clinicopathologic characteristics of multiple myeloma with cutaneous involvement: A case series from Korea.
Woo YR; Kim JS; Lim JH; Hwang S; Kim M; Bae JM; Park YM; Min CK; Kim DW; Park HJ
J Am Acad Dermatol; 2018 Mar; 78(3):471-478.e4. PubMed ID: 29107338
[TBL] [Abstract][Full Text] [Related]
59. IgG-cryoglobulin consisting of both kappa and lambda light chains and beta 1C/1A.
Arakawa M; Ono I; Ito S; Mihara A; Tashiro A
Tohoku J Exp Med; 1979 Nov; 129(3):295-301. PubMed ID: 118545
[TBL] [Abstract][Full Text] [Related]
60. Multiple myeloma and multiple plasmacytomas associated with free gamma heavy chain, free kappa light chain and IgGk paraproteins: an unusual triple gammopathy.
Deighan WI; O'Kane MJ; McNicholl FP; Keren DF
Ann Clin Biochem; 2016 Nov; 53(6):706-711. PubMed ID: 27166317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
